Trazodone 150mg tablets

Pays: Royaume-Uni

Langue: anglais

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ingrédients actifs:

Trazodone hydrochloride

Disponible depuis:

Flamingo Pharma (UK) Ltd

Code ATC:

N06AX05

DCI (Dénomination commune internationale):

Trazodone hydrochloride

Dosage:

150mg

forme pharmaceutique:

Oral tablet

Mode d'administration:

Oral

classe:

No Controlled Drug Status

Type d'ordonnance:

Valid as a prescribable product

Descriptif du produit:

BNF: 04030100; GTIN: 5060464501128

Notice patient

FONTS SIZE :
Generic Name font size : 12 pt.
Composition fonts size : 8.5 pt.
FONTS : Zurich CnBT
210 mm
340 mm
210 mm
WHAT IS IN THIS LEAFLET
1. What Trazodone Hydrochloride Tablets are and what they are used for
2. What you need to know before you take Trazodone Hydrochloride
Tablets
3. How to take Trazodone Hydrochloride Tablets
4. Possible side effects
5. How to store Trazodone Hydrochloride Tablets
6. Contents of the pack and other information
1. WHAT TRAZODONE HYDROCHLORIDE TABLETS ARE AND WHAT THEY ARE USED FOR
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE TRAZODONE HYDROCHLORIDE TABLETS
3. HOW TO TAKE TRAZODONE HYDROCHLORIDE TABLETS
4. POSSIBLE SIDE EFFECTS
5. HOW TO STORE TRAZODONE HYDROCHLORIDE TABLETS
6. CONTENTS OF THE PACK AND OTHER INFORMATION
POM
MARKETING AUTHORIZATION HOLDER
FLAMINGO PHARMA (UK) LTD.
1st Floor, Kirkland House, 11-15 Peterborough Road, Harrow, Middlesex,
HA1 2AX, United Kingdom.
MANUFACTURER
FLAMINGO PHARMA (UK) LIMITED,
The Bloc, 38 Springfield Way,
Anlaby, Hull, HU10 6RJ,
United Kingdom
PACKAGE LEAFLET: INFORMATION FOR THE USER
TRAZODONE HYDROCHLORIDE 150MG FILM-COATED TABLETS
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor or pharmacist.
•
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their symptoms are the same as
yours.
•
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects not listed in this leaflet. See
section 4.
The name of your medicine is Trazodone Hydrochloride 150mg Film-coated
Tablets (called Trazodone Hydrochloride Tablets in this leaflet).
Trazodone
Hydrochloride Tablets contain a medicine called trazodone
hydrochloride.
This belongs to a group of medicines called antidepressants.
Trazodone Hydrochloride Tablets can be used to treat anxiety and
depression.
•
You are allergic (

Résumé des caractéristiques du produit

OBJECT 1
TRAZODONE 150 MG TABLETS
Summary of Product Characteristics Updated 15-Jun-2020 | Flamingo
Pharma (UK) Ltd
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Fertility, pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Trazodone Hydrochloride 150 mg Film-coated Tablets
2. Qualitative and quantitative composition
Each film-coated tablet contains 150mg of Trazodone Hydrochloride.
Excipient(s) with known effect:
Each film-coated tablet contains 82.00 mg lactose monohydrate.
For full list of excipients, see section 6.1.
3. Pharmaceutical form
Film-coated Tablet
Pink, approx 10 mm round, biconvex film coated tablet debossed with
“T” on upper side of breakline and
plain on other side.
The tablet can be divided into equal doses.
4. Clinical particulars
4.1 Therapeutic indications
Relief of symptoms in all types of depression including depression
accompanied by anxiety.
4.2 Posology and method of administration
Route of administration: Oral.
DEPRESSION:
a) Adults:
Initially 150mg/day in divided doses after food or as a single do